Genotypic Analysis
The NS5b region of hepatitis C virus is more accurate for determining subtypes
Published in Hepatitis Weekly, August 23rd, 2004
According to a study from France, "hepatitis C virus (HCV) strains isolated from 68 hemodialysis Tunisian patients exhibiting chronic infection were genotyped targeting the NS5b region of the HCV genome using a prototype assay developed by Bayer HealthCare-Diagnostics (TRUGENE NS5b HCV). The overall results were compared to those obtained with another assay of the same company based on sequencing of the 5' non-coding region (TRUGENE HCV 5'NC genotyping kit). All strains could be typed by the 5'NC typing kit, but only 62 (91.2%) by the NS5b prototype assay."
"All the 62...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2004-08-23)
More Articles from Hepatitis Weekly
- Chronic Hepatitis C
Consensus interferon and lactoferrin don't improve hepatitis C response rates - Diagnostics
Short-term hepatitis C virus infections reveal novel epitopes - Pediatric Cancer
HCV-associated liver disease in young cancer survivors shadows adult illness - Zoonotic Disease
Avian hepatitis E virus shares the features of swine and human HEV - Adverse Side Effects
Pegylated interferon causes dystonia in some patients infected with hepatitis B - Antiretroviral Therapy
Antiretroviral emtricitabine (FTC) has low toxicity in HIV-infected patients - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
